Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?

No matter what your reasons for investing may be, you would probably be thrilled with a stock that turns a relatively small amount of money -- say, $50,000 -- into a million dollars. Finding companies of this caliber can be a daunting task: There are near-endless options on the market, but most stocks will never deliver these kinds of gains.

Today, let's take a closer look at clinical-stage biotech company Inovio Pharmaceuticals (NASDAQ: INO) and see whether it has what it takes to join that select group of millionaire-maker stocks. Inovio rose to prominence last year thanks to its efforts to develop a vaccine for COVID-19, and its shares are up by 277% over the past 12 months as a result, compared to gains of 16% for the S&P 500 in the same period. Can the biotech keep up the momentum moving forward?